Trial intelligence / Profile preview

Vasopressors and Innate Immune Response in Experimental Human Endotoxemia

NCT02675868Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Jan 2016
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of norepinephrine in septic shock, sponsored by Radboud University Medical Center. Started Jan 2016; status: completed.

02

Drugs

norepinephrine
03

Conditions

septic shock

Beyond the preview

Go deeper on NCT02675868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02675868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call